Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59.6M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
7.9M
-
Shares change
-
+1.79M
-
Total reported value, excl. options
-
$38M
-
Value change
-
+$8.37M
-
Number of buys
-
16
-
Number of sells
-
-6
-
Price
-
$5.00
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2017
26 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2017.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.9M shares
of 59.6M outstanding shares and own 13.26% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (2.89M shares), FMR LLC (1.71M shares), AWM Investment Company, Inc. (913K shares), SPHERA FUNDS MANAGEMENT LTD. (669K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (475K shares), VANGUARD GROUP INC (295K shares), Boxer Capital, LLC (291K shares), SABBY MANAGEMENT, LLC (180K shares), Knoll Capital Management, LP (124K shares), and MILLENNIUM MANAGEMENT LLC (103K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.